AKBA
Akebia Therapeutics, Inc.1.31post−$0.01 (−0.76%)at close +$0.00 (+0.00%)
as of 19:59:56 UTCnext report Aug 6 · tomorrow
Earnings Room‹ back to AKBA
The report
fiscal Q2 2026 · from the company's noticeAug 6before open1day out
Expected movement
market-implied · at the Aug 4 close±15.6%is what the chain prices for this report itself, with the ordinary drift of the days around it taken out. Not a view we hold.
The full straddle prices ±32.4% over the 17 days to expiry; the rest of that is everyday movement, which the chain prices at 174% annualized.
expiry Aug 21 · first after the reportATM strike 1.5straddle 0.50ATM IV 199% vs 184% at Sep 18× 0.85 straddle-to-rangespot 1.31
Blast radius
3 linked · N-PORT + EDGARIf AKBA moves ±32.4% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.
Positioning
4 expiries · as of the Aug 4 closeContracts already committed, not just traded today — puts against calls, sized by expiry. The tick is today's volume moving against that stance; the arrow, how much built up since the prior session.
OI ΔPutsOI
ExpiryOICallsOI Δ
▲ +0%
8
Aug 21
17d
3.5k▲ +3%
first
0
Sep 18
45d
29▲ +0%
▲ +0%
1.9k
Oct 16
73d
1.6k
▼ −1%
▲ +0%
2.2k
Jan 15
164d
13.5k▼ −0%
The record
expected in pale · actual in full color1/8reports moved further than the options market had pricedtypically ±12.7% realized vs ±17.9% priced
May 7 '26±14.2%→−20.3%×1.43
Feb 26 '26±27.1%→+9.1%×0.34
Jan 12 '26±13.3%→−7.9%×0.59
Nov 10 '25±20.4%→−18.1%×0.89
Aug 7 '25±30.2%→−20.5%×0.68
May 8 '25±12.4%→+6.5%×0.52
Mar 13 '25±14.7%→−12.4%×0.84
Nov 7 '24±10.6%→−6.8%×0.64
pale = implied the day beforeink = the next day's close× = realized ÷ implied
2-quarter memory
Q1 FY26 · reported -0.03 · rev $54M
record note
The note composes when the report lands. Nothing is written for a quarter that hasn't been read.